CN113974167A - Meal replacement food and preparation method thereof - Google Patents
Meal replacement food and preparation method thereof Download PDFInfo
- Publication number
- CN113974167A CN113974167A CN202111327035.2A CN202111327035A CN113974167A CN 113974167 A CN113974167 A CN 113974167A CN 202111327035 A CN202111327035 A CN 202111327035A CN 113974167 A CN113974167 A CN 113974167A
- Authority
- CN
- China
- Prior art keywords
- parts
- meal replacement
- edible
- replacement food
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 53
- 235000012054 meals Nutrition 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title abstract description 32
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000000843 powder Substances 0.000 claims abstract description 45
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 23
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 23
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 23
- 239000001103 potassium chloride Substances 0.000 claims abstract description 21
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 21
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims abstract description 16
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229920002581 Glucomannan Polymers 0.000 claims abstract description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 16
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 16
- 229940046240 glucomannan Drugs 0.000 claims abstract description 16
- 239000008103 glucose Substances 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 16
- 239000000661 sodium alginate Substances 0.000 claims abstract description 16
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 16
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 16
- 229940013618 stevioside Drugs 0.000 claims abstract description 16
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000019202 steviosides Nutrition 0.000 claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008213 purified water Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 36
- 238000002156 mixing Methods 0.000 claims description 21
- 238000009835 boiling Methods 0.000 claims description 19
- 238000005469 granulation Methods 0.000 claims description 19
- 230000003179 granulation Effects 0.000 claims description 19
- 235000002639 sodium chloride Nutrition 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 18
- 239000000853 adhesive Substances 0.000 claims description 10
- 230000001070 adhesive effect Effects 0.000 claims description 10
- 238000005507 spraying Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 244000099147 Ananas comosus Species 0.000 claims description 6
- 235000007119 Ananas comosus Nutrition 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 4
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 3
- 240000002319 Citrus sinensis Species 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 19
- 229920001223 polyethylene glycol Polymers 0.000 abstract description 17
- 239000002202 Polyethylene glycol Substances 0.000 abstract description 16
- 210000000683 abdominal cavity Anatomy 0.000 abstract description 11
- 210000001835 viscera Anatomy 0.000 abstract description 10
- 235000020888 liquid diet Nutrition 0.000 abstract description 6
- 208000002193 Pain Diseases 0.000 abstract description 5
- 230000008855 peristalsis Effects 0.000 abstract description 5
- 238000001356 surgical procedure Methods 0.000 abstract description 5
- 238000001839 endoscopy Methods 0.000 description 27
- 210000001035 gastrointestinal tract Anatomy 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 230000035568 catharsis Effects 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 239000003792 electrolyte Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 239000002002 slurry Substances 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000002052 colonoscopy Methods 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 206010068797 Anastomotic fistula Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- -1 ethylenediaminetetraacetic acid sodium iron oxide Chemical compound 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940076742 senna leaves Drugs 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention provides a meal replacement food, which comprises: 1-60 parts of edible glucose, 1-50 parts of maltodextrin, 1-30 parts of fruit powder, 0.1-5 parts of edible citric acid, 0.1-2 parts of DL malic acid, 0.05-1.5 parts of glucomannan, 0.1-5 parts of sodium alginate, 0.01-1.5 parts of edible salt, 0.01-0.75 part of potassium chloride, 0.01-0.5 part of stevioside and 0.5-50 parts of purified water. The meal replacement food provided by the invention can stimulate intestinal peristalsis, promote intestinal evacuation, reduce the use amount of polyethylene glycol used by an inspector by at least half, reduce the pain degree of the inspector, greatly improve the definition of endoscopic examination and significantly improve the safety of intestinal surgery and other visceral organ surgery in the abdominal cavity before the inspector eats the liquid diet. The invention also provides a preparation method of the meal replacement food.
Description
Technical Field
The invention belongs to the technical field of food, and particularly relates to meal replacement food and a preparation method thereof, in particular to meal for endoscopic examination, intestinal surgery and other visceral organ surgery in abdominal cavity and a preparation method thereof.
Background
Digestive tract diseases are frequently encountered diseases and common diseases in modern society, particularly, the canceration and lesion of the intestinal tract are in an ascending trend, endoscopy is an important means for finding the lesion of the mucous membrane of the digestive tract, and intestinal tract operation, hepatobiliary operation and gynecological operation are medical measures for relieving the diseases of patients. What kind of method is adopted in gastroenterology, the gastroenterology of medical institution does benefit to that the endoscopy observes intestinal mucosa pathological change, gastroenterology, and anorectal branch of academic or vocational study prevents that excrement and urine from spilling over and polluting the abdominal cavity in the art, or excrement and urine gets into the abdominal cavity and injures the intestinal in gastroenterology, hepatobiliary surgery, gynaecology and obstetrics prevent the art by mistake when the anastomotic fistula takes place, and excrement and urine spills over and pollutes the abdominal cavity and is an urgent troublesome problem that waits to solve, and for this reason, the cleanness of intestinal seems to be especially important.
At present, two main methods for cleaning the intestinal tract are provided, firstly, a control method of low-residue diet such as liquid diet is adopted within a few days before examination, so that the excrement in the intestinal tract is discharged and reduced, and then the diarrhea is carried out by adopting laxatives such as Chinese medicines such as senna leaves; the second is to purge the patient with a synthetic purgative such as magnesium sulfate, phosphate or PEG.
Disclosure of Invention
In view of the above, the present invention aims to provide a meal replacement food and a preparation method thereof, wherein the meal replacement food provided by the present invention can stimulate intestinal peristalsis, promote intestinal emptying, and improve the definition of endoscopy.
The invention provides a meal replacement food which comprises the following components in parts by weight:
1-80 parts of edible glucose;
1-80 parts of maltodextrin;
1-50 parts of fruit powder;
0.1-5 parts of edible citric acid;
0.1-2 parts of DL malic acid;
0.05-3 parts of glucomannan;
0.1-2 parts of sodium alginate;
0.01-1.5 parts of edible salt;
0.01-0.75 parts of potassium chloride;
0.01-0.5 parts of stevioside;
0.5-20 parts of water.
Preferably, the fruit powder is selected from one or more of lemon powder, sweet orange powder, pineapple powder and strawberry powder.
Preferably, the water is purified water.
The invention provides a preparation method of the meal replacement food in the technical scheme, which comprises the following steps:
mixing and granulating edible glucose, maltodextrin, fruit powder, edible citric acid, DL malic acid, glucomannan, sodium alginate, edible salt, potassium chloride, stevioside and water to obtain the meal replacement food.
Preferably, the granulation method is boiling granulation.
Preferably, the preparation method of the meal replacement food specifically comprises the following steps:
mixing and sieving edible citric acid, glucomannan, DL malic acid, edible salt, potassium chloride, stevioside and part of maltodextrin to obtain a sieved material;
mixing the sieved material with the rest maltodextrin, edible glucose and fruit powder at a high speed to obtain a mixture;
spraying the mixture into a binding agent under a heating state for boiling granulation to obtain a meal replacement food;
the adhesive comprises: sodium alginate and water.
Preferably, the method of mixing and screening is an equivalent incremental method.
Preferably, the rotation speed of the high-speed mixing is 1800-2200 rpm.
Preferably, the air inlet temperature of the boiling granulation is 75-85 ℃; the exhaust temperature is 45-55 ℃.
Preferably, the water content in the meal replacement food is less than or equal to 2.5 wt%.
The invention provides a meal replacement food for endoscopy, intestinal tract operation and other visceral organ operation in abdominal cavity, wherein before the endoscopy, an examiner eats the preparation one day before eating liquid diet, the preparation can stimulate intestinal peristalsis, promote intestinal evacuation, reduce the use amount of polyethylene glycol by the examiner by at least half, effectively increase the probability of one-time passing examination of the examiner, reduce the pain degree of the examiner, greatly improve the definition of endoscopy, and significantly improve the safety of the intestinal tract operation and other visceral organ operation in abdominal cavity. Meanwhile, the intestinal tract cleaning meal replacement preparation in the prior art is liquid, has a complex preparation process, is not easy to carry and has a short shelf life; the meal replacement food provided by the invention is a granular preparation, has the advantages of simple preparation process, quick dissolution, convenience for storage, long shelf life, convenience for carrying and better effect.
Drawings
FIG. 1 is a flow chart of a process for preparing a meal replacement food product according to an embodiment of the present invention;
FIG. 2 is a graph of stool trait scoring criteria under visual inspection during assessment of bowel preparation;
fig. 3 is a graph of visual field clarity scoring criteria under a colonoscope for evaluation of bowel preparation.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other examples, which may be modified or appreciated by those of ordinary skill in the art based on the examples given herein, are intended to be within the scope of the present invention. It should be understood that the embodiments of the present invention are only for illustrating the technical effects of the present invention, and are not intended to limit the scope of the present invention. In the examples, the methods used were all conventional methods unless otherwise specified.
The invention provides a meal replacement food which comprises the following components in parts by weight:
1-80 parts of edible glucose;
1-80 parts of maltodextrin;
1-50 parts of fruit powder;
0.1-5 parts of edible citric acid;
0.1-2 parts of DL malic acid;
0.05-3 parts of glucomannan;
0.1-2 parts of sodium alginate;
0.01-1.5 parts of edible salt;
0.01-0.75 parts of potassium chloride;
0.01-0.5 parts of stevioside;
0.5-20 parts of water.
The invention provides a meal replacement food for endoscopy, intestinal tract operation and other visceral organ operation in abdominal cavity.
In the invention, the weight part of the edible glucose is preferably 1-60 parts, more preferably 20-50 parts, more preferably 30-40 parts, and most preferably 35 parts.
In the present invention, the maltodextrin is preferably 1 to 50 parts by weight, more preferably 10 to 40 parts by weight, more preferably 20 to 30 parts by weight, and most preferably 25 parts by weight.
In the invention, the fruit powder is preferably selected from one or more of lemon powder, sweet orange powder, pineapple powder and strawberry powder.
In the invention, the weight part of the fruit powder is preferably 1-30 parts, more preferably 10-20 parts, and most preferably 15 parts.
In the invention, the weight part of the edible citric acid is preferably 0.1-3 parts, more preferably 0.1-0.5 part, more preferably 0.2-0.4 part, and most preferably 0.3 part.
In the invention, the weight part of the DL malic acid is preferably 0.1-1 part, and more preferably 0.1-0.2 part.
In the present invention, the weight part of the glucomannan is preferably 0.05 to 1.5 parts, more preferably 0.05 to 0.3 parts, and most preferably 0.1 to 0.2 parts.
In the invention, the weight part of the sodium alginate is preferably 0.1-1 part, more preferably 0.1-0.6 part, more preferably 0.2-0.5 part, and most preferably 0.3-0.4 part.
In the invention, the weight part of the edible salt is preferably 0.01-1 part, more preferably 0.03-0.2 part, more preferably 0.05-0.15 part, more preferably 0.08-0.12 part, and most preferably 0.1 part.
In the present invention, the weight part of the potassium chloride is preferably 0.01 to 0.5 part, more preferably 0.02 to 0.1 part, more preferably 0.03 to 0.08 part, more preferably 0.04 to 0.06 part, and most preferably 0.05 part.
In the invention, the weight part of the stevioside is preferably 0.01-0.1 part, more preferably 0.02-0.08 part, more preferably 0.03-0.06 part, and most preferably 0.04-0.05 part.
In the present invention, the water is preferably purified water.
In the present invention, the water is preferably 0.5 to 15 parts by weight, more preferably 0.5 to 8 parts by weight, more preferably 1 to 6 parts by weight, more preferably 2 to 5 parts by weight, and most preferably 3 to 4 parts by weight.
The invention provides a preparation method of the meal replacement food in the technical scheme, which comprises the following steps:
mixing and granulating edible glucose, maltodextrin, fruit powder, edible citric acid, DL malic acid, glucomannan, sodium alginate, edible salt, potassium chloride, stevioside and water to obtain the meal replacement food.
In the present invention, the method of granulation is preferably boiling granulation.
In the invention, the preparation method of the meal replacement food preferably specifically comprises the following steps:
mixing and sieving edible citric acid, glucomannan, DL malic acid, edible salt, potassium chloride, stevioside and part of maltodextrin to obtain a sieved material;
mixing the sieved material with the rest maltodextrin, edible glucose and fruit powder at a high speed to obtain a mixture;
spraying the mixture into a binding agent under a heating state for boiling granulation to obtain a meal replacement food;
the adhesive comprises: sodium alginate and water.
In the present invention, the mass of the part of maltodextrin is the same as the total mass of edible citric acid, glucomannan, DL-malic acid, edible salt, potassium chloride and stevioside.
In the present invention, the mixing and screening method is preferably an equivalent incremental method.
According to the invention, edible citric acid, glucomannan, edible salt, potassium chloride and stevioside are mixed and sieved by an equivalent incremental method, so that small-dose materials are fully and uniformly mixed, and edible glucose, maltodextrin and fruit powder are mixed with the fully and uniformly mixed small-dose materials by using a high-speed mixer, so that the uniformity of the materials is ensured. The invention adopts a low-residue diet formula, provides a certain amount of energy for inspectors before endoscopy or patients with intestinal tract and viscera operators and enhances the cleanness of the intestinal tract, and after the inspectors eat liquid diet one day before endoscopy or the next day after operation, the preparation can stimulate the intestinal peristalsis, promote the emptying of the intestinal tract, reduce the usage amount of polyethylene glycol used by the inspectors by at least half, effectively increase the one-time passing probability of the inspectors, reduce the pain degree of the inspectors, greatly improve the definition of endoscopy, and significantly improve the safety of intestinal tract operation and other visceral organ operations in the abdominal cavity.
In the invention, the mixing and sieving preferably adopts a stainless steel sieve; the mesh number of the mixing and sieving is preferably 55-65 meshes, more preferably 58-62 meshes, and most preferably 60 meshes; the number of passes of the mixing and sieving is preferably 2 to 4, and more preferably 3.
In the present invention, the high-speed mixing is preferably carried out in a high-speed mixer; the high-speed mixing rotation speed is preferably 1800-2200 rpm, more preferably 1900-2100 rpm, and most preferably 2000 rpm; the time for the high speed mixing is preferably 2 to 4 minutes, more preferably 2.5 to 3.5 minutes, and most preferably 3 minutes.
In the invention, the adhesive is preferably an aqueous sodium alginate solution, and the mass concentration of the aqueous sodium alginate solution is preferably 6-7%, more preferably 6.1-6.5%, more preferably 6.2-6.4%, and most preferably 6.25%.
In the invention, the air inlet temperature in the boiling granulation process is preferably 75-85 ℃, more preferably 78-82 ℃, and most preferably 78 ℃; the air exhaust temperature is preferably 45-55 ℃, more preferably 48-52 ℃ and most preferably 50 ℃.
In the invention, the slurry spraying (binder) time in the boiling granulation process is preferably 13-17 minutes, more preferably 14-16 minutes, and most preferably 15 minutes.
In the invention, the drying time in the boiling granulation process is preferably 55-65 minutes, more preferably 58-62 minutes, and most preferably 60 minutes.
In the invention, the moisture after drying in the boiling granulation process, namely the moisture in the prepared meal replacement food, is preferably less than or equal to 2.5 wt%.
The meal replacement food for endoscopy, intestinal tract operation and other visceral organ operation provided by the invention is prepared by four procedures of mixing, boiling granulation, drying and packaging (the process flow is shown in figure 1), and the defects that the intestinal tract cleaning meal replacement preparation in the prior art is liquid, the process is complex, the carrying is not convenient and the quality guarantee period is short are overcome. The product provided by the invention is a granular preparation, has simple preparation process, quick dissolution and fruity flavor, can provide energy and reduce slag, effectively reduces the using amount of a cathartic during diarrhea and the pain degree of a user, is convenient to store, has long shelf life, is convenient to carry and has better effect.
The starting materials used in the following examples of the present invention are all commercially available products.
Example 1
0.28kg of edible citric acid, 0.65kg of edible salt and 0.25kg of potassium chloride are ground into fine powder with the particle size of below 60 meshes, then the fine powder, 0.19kg of glucomannan and 0.05kg of stevioside are fully and uniformly mixed, 1.42kg of maltodextrin with the same amount is added and uniformly mixed, then the mixture is sieved for three times through a 60-mesh stainless steel sieve, and the sieved material, 41.58kg of the remaining maltodextrin, 40kg of edible glucose and 17kg of pineapple powder are mixed in a high-speed mixer for three minutes at the rotating speed of 2000 rpm, so that the uniformly mixed material is obtained.
0.5kg of sodium alginate is mixed with 8kg of water to swell, and the adhesive for guniting is prepared.
And adding the uniformly mixed materials into a boiling granulator for boiling granulation, setting the air inlet temperature to be 78 ℃, the air outlet temperature to be 50 ℃, the slurry (adhesive) spraying time to be 15 minutes, drying for 60 minutes after slurry spraying, and discharging, wherein the water content is controlled to be less than or equal to 2.5%, so as to obtain the granules.
And filling the dried particles into a package of 26 g/bag by using a particle packaging machine to obtain the meal replacement food.
Example 2
0.28kg of edible citric acid, 0.65kg of edible salt and 0.25kg of potassium chloride are ground into fine powder with the granularity of less than 60 meshes, then the fine powder, 0.19kg of glucomannan and 0.05kg of stevioside are fully and uniformly mixed, 1.42kg of maltodextrin with the same quantity is added and uniformly mixed, then the mixture is sieved for three times through a 60-mesh stainless steel sieve, and the sieved material, the rest 31.58kg of maltodextrin, 50kg of edible glucose and 17kg of pineapple powder are mixed in a high-speed mixer for three minutes at the rotating speed of 2000 rpm, so that the uniformly mixed material is obtained.
0.5kg of sodium alginate is mixed with 8kg of water to swell, and the adhesive for guniting is prepared.
And adding the uniformly mixed materials into a boiling granulator for boiling granulation, setting the air inlet temperature to be 78 ℃, the air outlet temperature to be 50 ℃, the slurry (adhesive) spraying time to be 15 minutes, drying for 60 minutes after slurry spraying, and discharging, wherein the water content is controlled to be less than or equal to 2.5%, so as to obtain the granules.
And filling the dried particles into a package of 26 g/bag by using a particle packaging machine to obtain the meal replacement food.
Example 3
0.28kg of edible citric acid, 0.65kg of edible salt and 0.25kg of potassium chloride are ground into fine powder with the granularity of less than 60 meshes, then the fine powder, 0.19kg of glucomannan and 0.05kg of stevioside are fully and uniformly mixed, 1.42kg of maltodextrin with the same quantity is added and uniformly mixed, then the mixture is sieved for three times by a 60-mesh stainless steel sieve, and the sieved material, 21.58kg of the rest maltodextrin, 60kg of edible glucose and 17kg of pineapple powder are mixed in a high-speed mixer for three minutes at the rotating speed of 2000 r/min to obtain the uniformly mixed material.
0.5kg of sodium alginate is mixed with 8kg of water to swell, and the adhesive for guniting is prepared.
And adding the uniformly mixed materials into a boiling granulator for boiling granulation, setting the air inlet temperature to be 78 ℃, the air outlet temperature to be 50 ℃, the slurry (adhesive) spraying time to be 15 minutes, drying for 60 minutes after slurry spraying, and discharging, wherein the water content is controlled to be less than or equal to 2.5%, so as to obtain the granules.
And filling the dried particles into a package of 26 g/bag by using a particle packaging machine to obtain the meal replacement food.
Comparative example 1
The method of the prior art is adopted: before the endoscopy examination, liquid diet is adopted three times a day, 2L of compound polyethylene glycol electrolyte powder (III) is adopted for catharsis once at 8 o' clock, and water is not fed after catharsis; in the next morning, 2L compound polyethylene glycol electrolyte powder (III) is used for catharsis once (each bag contains 400064.000 g polyethylene glycol, 5.700g anhydrous sodium sulfate, 1.460g sodium chloride, 0.750g potassium chloride, and 1.680g sodium bicarbonate, and is dissolved in warm boiled water); endoscopy was performed in the afternoon.
Comparative example 2
Adopting a food replacement can for intestinal endoscopy (comprising 79.3 parts of water, 1 part of xanthan gum, 3 parts of konjac powder, 3 parts of whey protein, 0.1 part of citric acid, a proper amount of edible essence, 0.7 part of sodium chloride, 0.1 part of magnesium sulfate, 12.5 parts of glucose and 0.3 part of potassium chloride in parts by weight) with a commercial product number of 2156735 as a food replacement on the day before endoscopy; the preparation is administered in four times (200 ml each time) and 800ml each time; 2L of compound polyethylene glycol electrolyte powder (III) is used for drainage once at 8 o' clock, and water is not taken after drainage; in the morning, 1L of compound polyethylene glycol electrolyte powder (III) is used for catharsis once (each bag contains 400064.000 g of polyethylene glycol, 5.700g of anhydrous sodium sulfate, 1.460g of sodium chloride, 0.750g of potassium chloride and 1.680g of sodium bicarbonate, and is dissolved in 1L of warm boiled water); endoscopy was performed in the afternoon.
Comparative example 3
Adopting a commercial food substitute (comprising 84 parts of maltodextrin, 5 parts of collagen, 10 parts of soybean protein and 1 part of premix (vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, folic acid, nicotinic acid, calcium pantothenate, taurine, zinc sulfate, calcium gluconate, tricalcium phosphate and ethylenediaminetetraacetic acid sodium iron oxide) with a commercial product number of 3854177 for intestinal endoscopy as a meal substitute on the day before endoscopy; 200g per day, and 50g for four times; 2L of compound polyethylene glycol electrolyte powder (III) is used for drainage once at 8 o' clock, and water is not taken after drainage; in the morning, 1L of compound polyethylene glycol electrolyte powder (III) is used for catharsis once (each bag contains 400064.000 g of polyethylene glycol, 5.700g of anhydrous sodium sulfate, 1.460g of sodium chloride, 0.750g of potassium chloride and 1.680g of sodium bicarbonate, and is dissolved in 1L of warm boiled water); endoscopy was performed in the afternoon.
Performance detection
After the meal replacement food prepared in the embodiment of the invention and the meal replacement food in the comparative example are eaten, the intestinal endoscopy clear degree and the endoscopy sufferings of inspectors are detected, and the specific method comprises the following steps:
756 cases of outpatients, inpatients and health examiners such as abdominal pain, diarrhea, constipation, hematochezia, abdominal mass and the like which are subjected to clinic visit are selected to be randomly divided into six groups according to time, sex and age, and the six groups are divided into three groups of a control group and three groups of an implementation group; implementation group 126 persons/group, control group 126 persons/group; the implementation group adopts the food substitute prepared by the embodiment of the invention as the food substitute before the intestinal endoscopy, and the control group adopts the traditional method and the commercial food substitute method. Each person in the group uses the meal replacement food prepared by the embodiment of the invention every day to replace meal every day before endoscopy, 8 bags are taken every day, 2 bags are taken every time, each bag is boiled by warm boiled water with the temperature of 70 ℃, then the meal replacement food is eaten after being warmed, and the meal replacement food is eaten up before 6 o' clock at night; the first cathartic compound polyethylene glycol electrolyte powder (III) is used for 1L catharsis once at 8 o' clock; no water is taken after catharsis; in the morning, 1L of compound polyethylene glycol electrolyte powder (III) is used for catharsis once (each bag contains 400064.000 g of polyethylene glycol, 5.700g of anhydrous sodium sulfate, 1.460g of sodium chloride, 0.750g of potassium chloride and 1.680g of sodium bicarbonate, and is dissolved in 1L of warm boiled water); endoscopy was performed in the afternoon. The control group was prepared by the method of comparative examples 1 to 3.
After the second catharsis, scoring the stool condition according to a Boston evaluation system and scoring a Boston intestinal tract preparation scoring table to score the intestinal tract examination definition, and counting abdominal distension, nausea, vomiting, dizziness and hypoglycemia conditions of the examiner in the endoscopic examination process; the scoring criteria for visual assessment of fecal traits during bowel preparation are shown in figure 2; evaluation of visual acuity scoring criteria for bowel preparation colonoscopy is shown in fig. 3; the results of the measurements are shown in tables 1 to 3.
TABLE 1 statistics of stool scores for examples and comparative examples
TABLE 2 statistics of visual acuity scores under colonoscopy examples and comparative examples
TABLE 3 statistical Table of symptoms appearing during examination of examples and comparative examples
Group of | Number of examples | Abdominal distention | Nausea and vomiting | Dizziness and hypoglycemia |
Example 1 | 126 | 7 | 1 | 0 |
Example 2 | 126 | 23 | 2 | 1 |
Example 3 | 126 | 12 | 1 | 0 |
Comparative example 1 | 126 | 63 | 3 | 10 |
Comparative example 2 | 126 | 25 | 5 | 9 |
Comparative example 3 | 126 | 31 | 4 | 5 |
As can be seen from tables 1 to 3, the food alternatives prepared in examples 1, 2 and 3 have substantially similar intestinal clarity in stool and examination and adverse symptoms in the endoscopic examination process according to the boston evaluation system in the endoscopic examination, and compared with the comparative example, the food alternatives prepared according to the boston evaluation system have significant advantages in statistical results of the intestinal clarity in stool and examination and the adverse symptoms in the endoscopic examination process; compared with the commercial liquid meal replacement food, the food has the advantages of simple process and long shelf life.
The invention provides a meal replacement food for endoscopy, intestinal tract operation and other visceral organ operation in abdominal cavity, wherein before the endoscopy, an examiner eats the preparation one day before eating liquid diet, the preparation can stimulate intestinal peristalsis, promote intestinal evacuation, reduce the use amount of polyethylene glycol by the examiner by at least half, effectively increase the probability of one-time passing examination of the examiner, reduce the pain degree of the examiner, greatly improve the definition of endoscopy, and significantly improve the safety of the intestinal tract operation and other visceral organ operation in abdominal cavity. Meanwhile, the intestinal tract cleaning meal replacement preparation in the prior art is liquid, has a complex preparation process, is not easy to carry and has a short shelf life; the meal replacement food provided by the invention is a granular preparation, has the advantages of simple preparation process, quick dissolution, convenience for storage, long shelf life, convenience for carrying and better effect.
While only the preferred embodiments of the present invention have been shown and described, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention.
Claims (10)
1. A meal replacement food comprises the following components in parts by weight:
1-80 parts of edible glucose;
1-80 parts of maltodextrin;
1-50 parts of fruit powder;
0.1-5 parts of edible citric acid;
0.1-2 parts of DL malic acid;
0.05-3 parts of glucomannan;
0.1-2 parts of sodium alginate;
0.01-1.5 parts of edible salt;
0.01-0.75 parts of potassium chloride;
0.01-0.5 parts of stevioside;
0.5-20 parts of water.
2. The meal replacement food as claimed in claim 1, wherein the fruit powder is one or more selected from lemon powder, sweet orange powder, pineapple powder and strawberry powder.
3. The meal replacement food product of claim 1, wherein the water is purified water.
4. A method of preparing the meal replacement food of claim 1, comprising:
mixing and granulating edible glucose, maltodextrin, fruit powder, edible citric acid, DL malic acid, glucomannan, sodium alginate, edible salt, potassium chloride, stevioside and water in sequence to obtain the meal replacement food.
5. The method according to claim 4, wherein the method of granulation is boiling granulation.
6. The method according to claim 4, comprising in particular:
mixing and sieving edible citric acid, glucomannan, DL malic acid, edible salt, potassium chloride, stevioside and part of maltodextrin to obtain a sieved material;
mixing the sieved material with the rest maltodextrin, edible glucose and fruit powder at a high speed to obtain a mixture;
spraying the mixture into a binding agent under a heating state for boiling granulation to obtain a meal replacement food;
the adhesive comprises: sodium alginate and water.
7. The method of claim 6 wherein said mixing and screening is an equal increment method.
8. The method of claim 6, wherein the high speed mixing is performed at a speed of 1800 to 2200 rpm.
9. The method according to claim 6, wherein the inlet air temperature of the boiling granulation is 75-85 ℃; the exhaust temperature is 45-55 ℃.
10. The method of claim 4, wherein the meal replacement food has a moisture content of less than or equal to 2.5 wt%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111327035.2A CN113974167A (en) | 2021-11-10 | 2021-11-10 | Meal replacement food and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111327035.2A CN113974167A (en) | 2021-11-10 | 2021-11-10 | Meal replacement food and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113974167A true CN113974167A (en) | 2022-01-28 |
Family
ID=79747685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111327035.2A Pending CN113974167A (en) | 2021-11-10 | 2021-11-10 | Meal replacement food and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113974167A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115067504A (en) * | 2022-06-29 | 2022-09-20 | 医林营海(江苏)营养科技有限公司 | Special medical food for intestinal tract preparation and preparation method thereof |
CN117297082A (en) * | 2023-11-01 | 2023-12-29 | 意润健康产业(广州)有限公司 | Meal replacement composition for inspection and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104489697A (en) * | 2014-12-19 | 2015-04-08 | 成都永安制药有限公司 | Mannan-oligosaccharide-containing meal replacement powder with health function and preparation method of mannan-oligosaccharide-containing meal replacement powder |
CN105795481A (en) * | 2016-03-24 | 2016-07-27 | 广州军区广州总医院 | Special nutritional supplement agent for preoperative patients |
CN108904439A (en) * | 2011-12-07 | 2018-11-30 | Msm创新有限公司 | Taste modification material is used to modify the purposes that gastrointestinal tract prepares composition taste |
CN109170472A (en) * | 2018-10-16 | 2019-01-11 | 鲲鱼健康药业江苏有限公司 | Direct drinking type acerola concentrate solid beverage |
CN109892601A (en) * | 2019-03-22 | 2019-06-18 | 健康元药业集团股份有限公司 | Food compositions and its preparation method and application |
CN110063441A (en) * | 2019-04-11 | 2019-07-30 | 山东亿海鹏生经贸有限公司 | A kind of compound maltodextrin fructose liquid composition of small-molecular peptides and preparation method thereof |
CN110959795A (en) * | 2019-12-25 | 2020-04-07 | 河南佳禾康生物食品科技有限公司 | Gamma-aminobutyric acid solid beverage and preparation method thereof |
CN111096416A (en) * | 2019-12-26 | 2020-05-05 | 宁波御坊堂生物科技有限公司 | Diet-depriving composition for weight-losing meal replacement and preparation method thereof |
-
2021
- 2021-11-10 CN CN202111327035.2A patent/CN113974167A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108904439A (en) * | 2011-12-07 | 2018-11-30 | Msm创新有限公司 | Taste modification material is used to modify the purposes that gastrointestinal tract prepares composition taste |
CN104489697A (en) * | 2014-12-19 | 2015-04-08 | 成都永安制药有限公司 | Mannan-oligosaccharide-containing meal replacement powder with health function and preparation method of mannan-oligosaccharide-containing meal replacement powder |
CN105795481A (en) * | 2016-03-24 | 2016-07-27 | 广州军区广州总医院 | Special nutritional supplement agent for preoperative patients |
CN109170472A (en) * | 2018-10-16 | 2019-01-11 | 鲲鱼健康药业江苏有限公司 | Direct drinking type acerola concentrate solid beverage |
CN109892601A (en) * | 2019-03-22 | 2019-06-18 | 健康元药业集团股份有限公司 | Food compositions and its preparation method and application |
CN110063441A (en) * | 2019-04-11 | 2019-07-30 | 山东亿海鹏生经贸有限公司 | A kind of compound maltodextrin fructose liquid composition of small-molecular peptides and preparation method thereof |
CN110959795A (en) * | 2019-12-25 | 2020-04-07 | 河南佳禾康生物食品科技有限公司 | Gamma-aminobutyric acid solid beverage and preparation method thereof |
CN111096416A (en) * | 2019-12-26 | 2020-05-05 | 宁波御坊堂生物科技有限公司 | Diet-depriving composition for weight-losing meal replacement and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
应欣;卢玉;李义;佟毅;张连慧;: "麦芽糊精的功能特性及其应用研究进展", 中国粮油学报, no. 12, pages 131 - 137 * |
田文静;罗红霞;林少华;邓志峰;: "代餐粉的研究进展", 食品科技, no. 09, pages 95 - 101 * |
盛秋;张林;: "加速康复外科理念下胰十二指肠切除术患者围手术期饮食管理", 中西医结合护理(中英文), no. 08, pages 207 - 210 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115067504A (en) * | 2022-06-29 | 2022-09-20 | 医林营海(江苏)营养科技有限公司 | Special medical food for intestinal tract preparation and preparation method thereof |
CN115067504B (en) * | 2022-06-29 | 2024-04-16 | 医林营海(江苏)营养科技有限公司 | Special medical food for intestinal tract preparation and preparation method thereof |
CN117297082A (en) * | 2023-11-01 | 2023-12-29 | 意润健康产业(广州)有限公司 | Meal replacement composition for inspection and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113974167A (en) | Meal replacement food and preparation method thereof | |
Sellink | Examination of the small intestine by means of duodenal intubation | |
Ward-McQuaid | Intestinal obstruction due to food | |
CN102783585A (en) | Feed for improving reproductive performance of sows | |
CN108783459B (en) | Pea protein low-residue nutritional formula product, preparation method and application thereof | |
Deo et al. | Absorption of Co58 Labeled Cyanocobalamin in Protein Deficiency: An Experimental Study in the Rhesus Monkey | |
CN110623257A (en) | Application of composition for intestinal tract in preparation of diagnosis and treatment product for intestinal tract disease | |
CN112076170A (en) | Tablet with function of relaxing bowels | |
CN107582717B (en) | Traditional Chinese medicine composition and preparation for senile constipation and preparation method thereof | |
CN102755590B (en) | Veterinary medicine for enhancing porcine growth performance and preparation method thereof | |
CN105582382A (en) | Pharmaceutical composition for post-operative nursing for cholangitis and preparation method of pharmaceutical composition | |
CN109463607A (en) | A kind of food digesting stomach fortifying, food and medicament dual-purpose solid beverage product of promoting the circulation of qi defaecation and preparation method thereof | |
CN1211128C (en) | Supersonic development agent for gastrointestinal tract and its preparing method | |
CN100348187C (en) | Climacteric health food | |
CN1088378C (en) | Oral Chinese medicine liquid for treating chronic superficial gastritis and its preparation | |
Reed et al. | The effect of glucose, galactose and sorbitol on gastric emptying in the young pig | |
CN117045709B (en) | Method for preventing and treating calculus by using Polygonum capitatum extract | |
CN106822161A (en) | The therapeutic action of ginseng saponin Rh 2 acute myocardial infarction | |
CN106822157A (en) | The therapeutic action of Ginsenoside compound K acute myocardial infarction | |
CN106822162A (en) | The therapeutic action of ginseng sapoglycoside Rg 3 acute myocardial infarction | |
CN107582960A (en) | A kind of medicine for treating renal failure and preparation method thereof | |
CN1284564C (en) | Oral Chinese traditional medicine preparation for treating constipation | |
CN109453323B (en) | Composition for improving irregular menstruation, application and preparation method thereof | |
CN104587246B (en) | A kind of Chinese medicine preparation for treating epigastric pain and preparation method thereof | |
Richardson et al. | Sprue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |